InMed Pharmaceuticals INM
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 0.64 | -0.73 | -2,816 | -3 | ||
| 2025Q4 | 1.06 | 104.63 | -0.51 | -2,103 | -2 | |
| 2025Q3 | 2.19 | 102.07 | -0.44 | -1,821 | -2 | |
| 2025Q2 | 3.25 | 104.24 | -0.43 | -1,820 | -2 | |
| 2025Q1 | 2.07 | 99.72 | -1.5 | -2,137 | -2 | |
| 2024Q4 | 4.74 | 99.25 | -3.72 | -2,254 | -3 | |
| 2024Q3 | 4.74 | 104.58 | -2.71 | -1,735 | -2 | |
| 2024Q2 | 5.31 | 103.99 | -3.66 | -2,034 | -2 | |
| 2024Q1 | 7.28 | 104.12 | -2.27 | -1,844 | -2 | |
| 2023Q4 | 8.32 | 116.01 | 1.03 | -1,645 | -1 | |
| 2023Q3 | 14 | 103.4 | -15.24 | -2,673 | -3 | |
| 2023Q2 | 18.53 | 170.04 | 5.6 | -437 | 0 | |
| 2023Q1 | 21.6 | 107.97 | 0.2 | -2,073 | -2 | |
| 2022Q4 | 40.4 | 106.8 | 10.4 | -2,137 | -2 | |
| 2022Q3 | 131.87 | 99.31 | -81.2 | -3,479 | -4 | |
| 2022Q2 | 235.2 | 82.85 | -260.8 | -6,520 | -8 | |
| 2022Q1 | 471.35 | 101.84 | -122 | -3,540 | -3 | |
| 2021Q4 | 655 | 100.68 | -157.2 | -4,312 | -4 | |
| 2021Q3 | 875 | 97.34 | -123.4 | -2,893 | -3 | |
| 2021Q2 | 1590 | 101.47 | -204.2 | -3,306 | -3 |